GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $167,520,000 | +60.0% | 3,848,409 | +60.1% | 0.04% | +95.5% |
Q1 2022 | $104,701,000 | -9.1% | 2,403,621 | -7.9% | 0.02% | -4.3% |
Q4 2021 | $115,130,000 | +23.7% | 2,610,635 | +7.2% | 0.02% | +15.0% |
Q3 2021 | $93,086,000 | +0.3% | 2,436,166 | +4.5% | 0.02% | -4.8% |
Q2 2021 | $92,791,000 | +32.2% | 2,330,261 | +18.5% | 0.02% | +23.5% |
Q1 2021 | $70,183,000 | +219.8% | 1,966,443 | +229.7% | 0.02% | +183.3% |
Q4 2020 | $21,949,000 | -16.3% | 596,416 | -14.4% | 0.01% | -25.0% |
Q3 2020 | $26,232,000 | +14.7% | 696,925 | +24.3% | 0.01% | +14.3% |
Q2 2020 | $22,872,000 | -30.5% | 560,733 | -35.4% | 0.01% | -50.0% |
Q1 2020 | $32,913,000 | +61.3% | 868,652 | +100.0% | 0.01% | +55.6% |
Q4 2019 | $20,410,000 | -14.7% | 434,358 | -22.6% | 0.01% | -18.2% |
Q3 2019 | $23,941,000 | +15.2% | 560,931 | +8.1% | 0.01% | +22.2% |
Q2 2019 | $20,775,000 | -47.2% | 519,110 | -44.9% | 0.01% | -55.0% |
Q1 2019 | $39,353,000 | +38.6% | 941,693 | +26.8% | 0.02% | +33.3% |
Q4 2018 | $28,384,000 | -37.2% | 742,836 | -34.0% | 0.02% | -25.0% |
Q3 2018 | $45,230,000 | +115.8% | 1,125,958 | +116.5% | 0.02% | +81.8% |
Q2 2018 | $20,962,000 | -7.8% | 520,019 | -10.6% | 0.01% | -8.3% |
Q1 2018 | $22,727,000 | -31.6% | 581,694 | -37.9% | 0.01% | -40.0% |
Q4 2017 | $33,221,000 | +1.5% | 936,598 | +16.2% | 0.02% | -23.1% |
Q3 2017 | $32,726,000 | -5.3% | 806,058 | +0.6% | 0.03% | -10.3% |
Q2 2017 | $34,558,000 | -13.1% | 801,424 | -15.0% | 0.03% | -21.6% |
Q1 2017 | $39,764,000 | +100.0% | 943,156 | +82.7% | 0.04% | +85.0% |
Q4 2016 | $19,878,000 | +245.0% | 516,175 | +286.4% | 0.02% | +233.3% |
Q3 2016 | $5,762,000 | +187.0% | 133,600 | +168.4% | 0.01% | +200.0% |
Q4 2015 | $2,008,000 | -40.7% | 49,784 | -43.5% | 0.00% | -33.3% |
Q3 2015 | $3,387,000 | -86.9% | 88,100 | -85.8% | 0.00% | -86.4% |
Q2 2015 | $25,784,000 | +1949.6% | 619,078 | +2170.4% | 0.02% | +2100.0% |
Q1 2015 | $1,258,000 | -58.8% | 27,267 | -61.8% | 0.00% | -66.7% |
Q4 2014 | $3,053,000 | -87.6% | 71,432 | -86.6% | 0.00% | -88.5% |
Q3 2014 | $24,533,000 | +635.0% | 533,654 | +754.9% | 0.03% | +550.0% |
Q2 2014 | $3,338,000 | -33.6% | 62,424 | -33.7% | 0.00% | -33.3% |
Q1 2014 | $5,028,000 | +39.6% | 94,099 | +39.5% | 0.01% | +20.0% |
Q4 2013 | $3,601,000 | -6.5% | 67,443 | -12.1% | 0.01% | -16.7% |
Q3 2013 | $3,850,000 | -62.9% | 76,757 | -63.0% | 0.01% | -66.7% |
Q2 2013 | $10,366,000 | – | 207,448 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |